共 50 条
- [1] Evaluation of the efficacy of tofacitinib as maintenance therapy in patients with Ulcerative Colitis stratified by OCTAVE Sustain baseline endoscopic subscore [J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 : S094 - S095
- [3] Tofacitinib as a maintenance therapy in patients with ulcerative colitis stratified by OCTAVE Sustain baseline Mayo endoscopic subscore [J]. BMC Gastroenterology, 23
- [4] Tofacitinib for Maintenance Therapy in Patients With Active Ulcerative Colitis in the Phase 3 OCTAVE Sustain Trial: Results by Local and Central Endoscopic Assessments [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S329 - S329
- [5] Time to Loss of Efficacy Following Tofacitinib Interruption in Patients With Ulcerative Colitis: Results From OCTAVE Sustain [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S405 - S406
- [7] Efficacy and safety of tofacitinib in Ulcerative Colitis patients with extraintestinal manifestations in OCTAVE Open [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I538 - I539
- [10] Efficacy and safety of tofacitinib in Ulcerative Colitis patients with extraintestinal manifestations in OCTAVE Open [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I538 - I539